Minerva Neurosciences, Inc.
NERV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,744 | -$3,259 | – | -$4,272 |
| Dep. & Amort. | $1 | $1 | – | $1 |
| Deferred Tax | $0 | $0 | – | $0 |
| Stock-Based Comp. | $0 | $0 | – | $250 |
| Change in WC | -$446 | $917 | – | -$1,146 |
| Other Non-Cash | $273 | $298 | – | $0 |
| Operating Cash Flow | -$2,916 | -$2,042 | – | -$5,167 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | – | $0 |
| Net Acquisitions | $0 | $0 | – | $0 |
| Inv. Purchases | $0 | $0 | – | $0 |
| Inv. Sales/Matur. | $0 | $0 | – | $0 |
| Other Inv. Act. | $0 | $0 | – | $0 |
| Investing Cash Flow | $0 | $0 | – | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | – | $0 |
| Stock Issued | $0 | $0 | – | $0 |
| Stock Repurch. | $0 | $0 | – | $0 |
| Dividends Paid | $0 | $0 | – | $0 |
| Other Fin. Act. | -$45 | $0 | – | $0 |
| Financing Cash Flow | -$45 | $0 | – | $0 |
| Forex Effect | $0 | $0 | – | $0 |
| Net Chg. in Cash | -$2,961 | -$2,042 | – | -$5,167 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,348 | $17,390 | – | $26,629 |
| End Cash | $12,387 | $15,348 | – | $21,462 |
| Free Cash Flow | -$2,916 | -$2,042 | – | -$5,167 |